Esperion Therapeutics, Inc.
US ˙ NasdaqGM ˙ US29664W1053

SecurityESPR / Esperion Therapeutics, Inc.
InstitutionCaption Management, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Caption Management, LLC ownership in ESPR / Esperion Therapeutics, Inc.

On May 15, 2024 - Caption Management, LLC filed a 13F-HR form disclosing ownership of 0 shares of Esperion Therapeutics, Inc. (US:ESPR) valued at $0 USD as of March 31, 2024. The entity filed a previous 13F-HR on February 14, 2024 disclosing 31,600 shares of Esperion Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Caption Management, LLC has a history of taking positions in derivatives of the underlying security (ESPR) in the form of stock options. The firm currently holds call options representing 2,074,000 of underlying shares valued at $5,682,760 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ESPR / Esperion Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-05-15 2024-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -31,600 -100.00 0 -100.00
2024-02-14 2023-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 31,600 31,600 94 0.0013
2022-11-14 2022-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -12,300 -100.00 0 -100.00
2022-08-15 2022-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 12,300 12,300 78 0.0011
2021-11-12 2021-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -25,589 -100.00 0 -100.00
2021-08-16 2021-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 25,589 939 3.81 542 -21.56 0.0071
2021-05-17 2021-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 24,650 24,650 -3.67 691 27.49 0.0149
2021-02-16 2020-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -3,000 -100.00 0 -100.00
2020-11-16 2020-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 3,000 -18,504 -86.05 111 -89.94 0.0026
2020-08-14 2020-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 21,504 7,804 56.96 1,103 155.92 0.0367
2020-05-15 2020-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 13,700 13,700 -36.29 431 -60.92 0.0244
2020-02-13 2019-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -4,400 -100.00 0 -100.00
2019-11-14 2019-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 4,400 4,400 161 0.0084
2019-05-14 2019-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -15,000 -100.00 0 -100.00
2019-01-30 2018-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 15,000 15,000 690 0.0551
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 2,074,000 -3.20 5,683 -28.32 n/a n/a n/a
2026-02-17 2025-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 2,142,500 7,927 n/a n/a n/a
2025-05-15 2025-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 323,800 -12.20 712 17.11 n/a n/a n/a
2024-11-14 2024-09-30 13F ESPERION THERAPEUTICS INC NE COM Call 368,800 0.00 609 -25.67 n/a n/a n/a
2024-08-14 2024-06-30 13F ESPERION THERAPEUTICS INC NE COM Call 368,800 63.91 819 35.66 n/a n/a n/a
2024-05-15 2024-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 225,000 0.00 603 -10.27 n/a n/a n/a
2024-02-14 2023-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 225,000 -39.81 673 83.61 n/a n/a n/a
2023-11-14 2023-09-30 13F ESPERION THERAPEUTICS INC NE COM Call 373,800 0.00 366 -29.48 n/a n/a n/a
2023-08-14 2023-06-30 13F ESPERION THERAPEUTICS INC NE COM Call 373,800 -55.87 520 -61.44 n/a n/a n/a
2023-05-15 2023-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 847,100 -51.96 1,347 -87.75 n/a n/a n/a
2023-02-14 2022-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 1,763,500 86.83 10,987 73.75 n/a n/a n/a
2022-11-14 2022-09-30 13F ESPERION THERAPEUTICS INC NE COM Call 943,900 6,323 n/a n/a n/a
2022-08-15 2022-06-30 13F ESPERION THERAPEUTICS INC NE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-13 2022-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 200,000 928 n/a n/a n/a
2021-11-12 2021-09-30 13F ESPERION THERAPEUTICS INC NE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F ESPERION THERAPEUTICS INC NE COM Call 75,000 1,586 n/a n/a n/a
2021-02-16 2020-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F ESPERION THERAPEUTICS INC NE COM Call 15,000 0.00 558 -27.53 n/a n/a n/a
2020-08-14 2020-06-30 13F ESPERION THERAPEUTICS INC NE COM Call 15,000 -44.44 770 -9.62 n/a n/a n/a
2020-05-15 2020-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 27,000 -66.25 852 -82.14 n/a n/a n/a
2020-02-13 2019-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 80,000 166.67 4,770 333.64 n/a n/a n/a
2019-11-14 2019-09-30 13F ESPERION THERAPEUTICS INC NE COM Call 30,000 -71.43 1,100 -77.48 n/a n/a n/a
2019-08-13 2019-06-30 13F ESPERION THERAPEUTICS INC NE COM Call 105,000 250.00 4,885 344.09 n/a n/a n/a
2019-05-14 2019-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-01-30 2018-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 30,000 1,380 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-08-14 2023-06-30 13F ESPERION THERAPEUTICS INC NE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-15 2023-03-31 13F ESPERION THERAPEUTICS INC NE COM Put 119,600 190 n/a n/a n/a
2022-11-14 2022-09-30 13F ESPERION THERAPEUTICS INC NE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F ESPERION THERAPEUTICS INC NE COM Put 25,000 159 n/a n/a n/a
2022-02-11 2021-12-31 13F ESPERION THERAPEUTICS INC NE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F ESPERION THERAPEUTICS INC NE COM Put 15,000 -89.31 181 -93.90 n/a n/a n/a
2021-08-16 2021-06-30 13F ESPERION THERAPEUTICS INC NE COM Put 140,300 14.53 2,967 -13.65 n/a n/a n/a
2021-05-17 2021-03-31 13F ESPERION THERAPEUTICS INC NE COM Put 122,500 -12.69 3,436 15.81 n/a n/a n/a
2021-02-16 2020-12-31 13F ESPERION THERAPEUTICS INC NE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F ESPERION THERAPEUTICS INC NE COM Put 15,000 0.00 558 -27.53 n/a n/a n/a
2020-08-14 2020-06-30 13F ESPERION THERAPEUTICS INC NE COM Put 15,000 -44.44 770 -9.62 n/a n/a n/a
2020-05-15 2020-03-31 13F ESPERION THERAPEUTICS INC NE COM Put 27,000 -10.00 852 -52.35 n/a n/a n/a
2020-02-13 2019-12-31 13F ESPERION THERAPEUTICS INC NE COM Put 30,000 0.00 1,788 62.55 n/a n/a n/a
2019-11-14 2019-09-30 13F ESPERION THERAPEUTICS INC NE COM Put 30,000 0.00 1,100 -21.20 n/a n/a n/a
2019-08-13 2019-06-30 13F ESPERION THERAPEUTICS INC NE COM Put 30,000 0.00 1,396 26.91 n/a n/a n/a
2019-05-14 2019-03-31 13F ESPERION THERAPEUTICS INC NE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-01-30 2018-12-31 13F ESPERION THERAPEUTICS INC NE COM Put 42,500 -71.67 1,955 -70.63 n/a n/a n/a
2018-11-14 2018-09-30 13F ESPERION THERAPEUTICS INC NE COM Put 150,000 6,656 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.